We study host-bacteria interactions using Listeria and MS-based Proteomics with a focus on Ubiquitin-like modifications (e.g. ISG15) and MHC complex peptides.

Joined October 2021
1 Photos and videos
Impens Lab retweeted
๐Ÿš€ Boosting bacterial immunopeptide discovery! Our bioinformatics workflow integrates 4 search engines with follow-up rescoring to enhance ID by 27%, maximizing the discovery of vaccine candidates. Applied to timsTOF/Thermo data๐Ÿฆ ๐Ÿ’‰ @ImpensLab ๐Ÿ”—Read: pubs.acs.org/doi/full/10.102โ€ฆ
1
7
9
369
14 Aug 2024
Excited to share our latest MCP article uncovering > 6,000 MHC class I immunopeptides in Listeria-infected mice, including 12 Listeria peptides and a potent CD8 T cell epitope. Many thanks to all co-authors for the excellent work! Read more at doi.org/10.1016/j.mcpro.2024โ€ฆ

4
13
508
Impens Lab retweeted
2 Oct 2023
๐Ÿ‘Congratulations to @kkariko & @weissmanlab on becoming #NobelPrize laureates. A lifetime achievement celebrating their important research on #mRNA technology in vaccines. ๐Ÿค”Did you know VIB, together with @VUBrussel, @ugent and participation of several international institutes helped establish the #BAXERNA consortium to further explore the potential of mRNA vaccines?
1
3
13
2,570
We are looking for a #postdoc position in #immunopeptidomics @ VIB & UGent with proteomics/peptidomics expertise to develop novel antibacterial #vaccines, see jobso.id/g492. A warm call to proteomics postdocs to apply!

14
18
1,945
Impens Lab retweeted
Research on #Moyamoya disease @ImpensLab: "Rare diseases result from dysregulated, often yet unknown molecular pathways. Investigating these conditions can lead to groundbreaking fundamental discoveries while opening treatment options for the patients."
2
4
627
31 Jan 2023
We are very excited and extremely grateful to receive this #ERCCoG grant from @ERC_Research. It is a recognition for the whole team and we thank @VIB_CMB @ugent @ugent_fge @VIBLifeSciences @FWOVlaanderen and many others for their continuous support!
31 Jan 2023
๐ŸŽŠ More wonderful @ERC_Research news! @ImpensLab has received an #ERC Consolidator grant for his research on #Moyamoya disease (#MMD). With this grant, the Impens Lab hopes to provide unprecedented insight into MMD-related immune responses! ๐Ÿ‘‰ bit.ly/3RgnPD7
11
5
71
7,866
31 Dec 2022
Another wonderful story from the Radoshevich lab. A must-read (and watch!) for all Listeria and comet tail aficionados.
7
1,500
Impens Lab retweeted
17 Oct 2022
๐Ÿ’‰ Francis Impens and team (@ImpensLab @VIB_PRC @VIB_CMB) design an mRNA vaccine against Listeria and open the door for other antibacterial vaccines. bit.ly/3g89LwR
1
5
26
17 Oct 2022
Finally published! Thank you all co-authors for their priceless contribution! Here we designed mRNA vaccine formulations against Listeria using immunopeptidomics Looking forward to continue our efforts to tackle other intracellular bacterial pathogens tinyurl.com/vaccineListeria

3
18
48
16 Sep 2022
Happy to share our new review on Moyamoya disease and RNF213, a disorder for which the etiology is still unknown. Here, we examined the recent body of literature suggesting immune-related insults as a trigger for Moyamoya disease onset. cell.com/trends/molecular-meโ€ฆ
1
7
24
Impens Lab retweeted
First day of the 4-day BePA Proteomics Summer School @ VIB starting with interesting talks on Proteomics applications and the DOs and DONTs of sample preparation ๐Ÿ‘‰๐Ÿ‘‰ bit.ly/3CELRCf #proteomics #tech #training #summerschool
3
9
23 Aug 2022
Very happy to share our work on mRNA vaccine formulations against Listeria MS and immunopeptidomics hold great promise to uncover antigens for next-generation vaccines, especially for intracellular bacteria. Incredibly grateful to all co-authors for their dedication and efforts!
2
7
16